| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.26 | 0.09 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.09 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |